Physician

Rajini Manjunath, MD

According to 2025 Medicare claims, Rajini Manjunath, MD (NPI: 1043207251) practices hematology/oncology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is ILLINOIS CANCER SPECIALISTS (NPI: 1164483913; TIN: 363980044) and primary practice location at 60123-9405.

Manjunath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,016 traditional Medicare patients, billed 143,600 HCPCS/CPT codes, and received $1,768,681 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 1,986 prescription claims across 401 beneficiaries totaling $2,606,163 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 13 claims. Open Payments data shows 21 records totaling $659. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,214,343 to $2,606,163. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,103	137,044	$1,924,230
2016	1,090	129,347	$1,877,604
2017	1,082	88,171	$1,875,240
2018	1,129	142,130	$2,358,011
2019	1,227	151,050	$2,579,873
2020	1,143	145,075	$2,704,754
2021	1,159	115,459	$2,446,207
2022	1,097	124,234	$2,434,428
2023	1,062	167,856	$2,538,840
2024	1,016	143,600	$1,768,681

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	307	1,745	$1,214,343
2016	306	1,694	$1,272,546
2017	325	1,687	$1,211,039
2018	345	1,937	$1,417,586
2019	361	1,973	$1,534,275
2020	360	2,009	$1,831,000
2021	423	1,926	$1,992,507
2022	375	1,918	$2,820,565
2023	414	2,004	$2,763,329
2024	401	1,986	$2,606,163

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	76	$43,855
2016	16	126	$42,374
2017	N/R	130	$35,675
2018	16	55	$8,596
2019	15	20	$1,451
2020	14	16	$1,356
2021	17	61	$4,179
2022	12	61	$3,807
2023	16	29	$2,403
2024	N/R	13	$1,017

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	208	384	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	532	1,206	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	246	1,086	$69
36415	Insertion of needle into vein for collection of blood sample	596	1,889	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	584	1,923	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	29	870	$476,652
Ibrance	Palbociclib	13	532	$298,276
Calquence	Acalabrutinib Maleate	22	660	$232,325
Tasigna	Nilotinib Hcl	12	336	$230,025
Promacta	Eltrombopag Olamine	13	390	$165,301

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	13	$1,017

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$659	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajini Manjunath, MD?

Tedicare shows public-source Medicare data for Rajini Manjunath, MD (NPI 1043207251), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajini Manjunath, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rajini Manjunath, MD?

Rajini Manjunath, MD is linked to ILLINOIS CANCER SPECIALISTS (billing NPI 1164483913) in the available physician profile data.

Does Rajini Manjunath, MD have Open Payments data?

Rajini Manjunath, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.